Lytix Biopharma AS
Industry
- Pharmaceuticals
- Biotechnology
- Large Molecule
Other Names/Subsidiaries
- Lytix Amicoat
Latest on Lytix Biopharma AS
Verrica Pharmaceuticals, Inc. ’ first-in-class oncolytic peptide asset, VP-315, has shown efficacy signals in a Phase II trial in patients with basal cell carcinoma (BCC) just a month after the firm w
The progression of investigational products through a series of increasingly sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for commer
Sanofi has appointed Dominique Carouge executive vice president head of business transformation, effective Feb. 15, 2018. He will join the executive committee and take charge of accelerating the
Pharmasum Therapeutics AS Gaustadalleen 21 NO-0349 Oslo, Norway Phone: +47 924 81 432 Web Site: www.pharmasum.com Contact: Anders Fugelli, PhD, CEO Industry Segment: Biopharmaceuticals B